ASX:LCT Living Cell Technologies (LCT) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free LCT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,622 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Living Cell Technologies alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Living Cell Technologies Stock (ASX:LCT)Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.Read More Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him LCT Stock News HeadlinesApril 23, 2024 | msn.comScientists discover 1st-of-its-kind cell part born from a swallowed microbeApril 18, 2024 | msn.comNew piece of technology at hospital in Pittsburgh helps save woman's lifeApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 14, 2024 | msn.comMicroscopes reveal a frozen moment in cellular time—a new method records cells as they workApril 5, 2024 | msn.comDefining a city using cell-phone dataApril 4, 2024 | msn.comEver wonder how smart a cell is? UC San Diego may soon find outMarch 26, 2024 | msn.comWill cell service work during the eclipse? Here’s what 3 carriers expectMarch 12, 2024 | msn.comAutomated high-throughput sorting of living cells using laser light and AIApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 11, 2024 | msn.comResearch team develops new technique to release and study individual proteins in cellsMarch 5, 2024 | msn.comResearchers demonstrate control of living cells with electronicsFebruary 22, 2024 | msn.comFirst-of-its-kind battery cell manufacturing facility coming to FargoFebruary 15, 2024 | msn.comProgramming cells to organize their molecules may open the door to new treatmentsJanuary 18, 2024 | msn.comNew technique visualizes mechanical structure of the cell nucleus for the first timeJanuary 18, 2024 | msn.comNew technique provides an unprecedented view inside the cell's control centerDecember 14, 2023 | msn.comNew method tags cells with location coordinates for single-cell studiesDecember 14, 2023 | msn.comSimplifying the way cell proliferation is monitored in miceDecember 6, 2023 | msn.comStartup gives new life to old technology — how a $109 million investment could help change the battery industryOctober 16, 2023 | news.yahoo.com40th anniversary of the first commercial cell phone callSeptember 26, 2023 | businesswire.comRed Cell Partners Launches Savoy Life, a Virtual Healthcare Platform for Long-Term CareSeptember 13, 2023 | uk.finance.yahoo.comLiving Cell Technologies Limited (LVCLF)September 1, 2023 | finance.yahoo.comLiving Cell Technologies Full Year 2023 Earnings: AU$0.002 loss per share (vs AU$0.002 loss in FY 2022)August 24, 2023 | msn.comCellares secures $255m for cell therapy development facilityAugust 23, 2023 | bizjournals.comSouth San Francisco cell therapy startup raises $255 millionAugust 11, 2023 | msn.com'From One Cell' Review: Blueprints for BuildingJuly 13, 2023 | technews.tmcnet.com3D Cell Culture Market worth $2.5 billion | MarketsandMarketsJuly 6, 2023 | msn.comThe Simplest Synthetic Cells Have Been Seen Evolving Faster Than Natural OnesSee More Headlines Receive LCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:LCT CUSIPN/A CIKN/A Webwww.lctglobal.com Phone61 3 8689 9997FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-54.06% Return on Assets-18.67% Debt Debt-to-Equity Ratio10.03 Current Ratio9.35 Quick Ratio17.84 Sales & Book Value Annual Sales$3,405.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.17 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.48 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. David Richard Hainsworth (Age 50)CEO & Exec. Chairman Comp: $40kMr. Daya UkaChief Financial OfficerDr. Belinda Di BartoloChief Operations OfficerDr. Carolyn M. Sue A.M. (Age 60)B.S., Ph.D., Member of Medical Advisory Board & Chief Medical Officer of NTCELL Comp: $50kMr. Madhukar Bhalla FCIS (Age 64)Company Sec. Comp: $40kDr. James A. MckennaChief Scientific OfficerMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersCarolyn SueSold 125,000 sharesTotal: $1,000.00 ($0.01/share) LCT Stock Analysis - Frequently Asked Questions How were Living Cell Technologies' earnings last quarter? Living Cell Technologies Limited (ASX:LCT) released its earnings results on Tuesday, February, 19th. The company reported $0.00 earnings per share (EPS) for the quarter. What other stocks do shareholders of Living Cell Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), AllianceBernstein Global High Income Fund (AWF). This page (ASX:LCT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Living Cell Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
